MedTrace Logo

Taperloc Versus Taplerloc Microplasty

NCT00757107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-03-14

No results posted yet for this study

Summary

This evaluation is conducted to evaluate the safety and performance of two different stem lengths of the Taperloc Total Hip System. Per implant bone loss and migration of the stem are compared between the two groups with Dual-energy X-ray absorptiometry (DEXA) and radiostereomektric analysis

Conditions

Interventions

DEVICE

Taperloc Microplasty

primary total hip arthroplasty

DEVICE

Taperloc standard

primary total hip arthroplasty

Sponsors & Collaborators

  • Biomet U.K. Ltd.

    collaborator INDUSTRY

  • Ingemar Ivarsson

    lead OTHER

Principal Investigators

  • Ingemar IVARSSON, PhD · University hospital of Linkoping

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-10-31
Completion
2015-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00757107 on ClinicalTrials.gov